SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF

A class of compounds as a SGLT1/SGLT2/DPP4 triple inhibitor, and an application in preparation of a drug serving as the SGLT1/SGLT2/DPP4 triple inhibitor. Compounds represented by formula (I), and isomers and pharmaceutically-acceptable salts thereof are specifically involved.

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD
description	A class of compounds as a SGLT1/SGLT2/DPP4 triple inhibitor, and an application in preparation of a drug serving as the SGLT1/SGLT2/DPP4 triple inhibitor. Compounds represented by formula (I), and isomers and pharmaceutically-acceptable salts thereof are specifically involved.
format	Patent
fullrecord	<record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_17629618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20220259247</sourcerecordid><originalsourceid>FETCH-uspatents_applications_176296183</originalsourceid><addsrcrecordid>eNrjZNAJdvcJCdZ3CQgwUfD08_B08gzxD1Jw9HNRcAwI8PF0dgzx9PdTCPFwDXL1d-NhYE1LzClO5YXS3Axqbq4hzh66pcUFiSWpeSXF8YkFBTmZyYklmfl5xfGG5mZGlmaGFsZEKwQAkRIrHQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF</title><source>USPTO Published Applications</source><creator>DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD</creator><creatorcontrib>DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD</creatorcontrib><description>A class of compounds as a SGLT1/SGLT2/DPP4 triple inhibitor, and an application in preparation of a drug serving as the SGLT1/SGLT2/DPP4 triple inhibitor. Compounds represented by formula (I), and isomers and pharmaceutically-acceptable salts thereof are specifically involved.</description><language>eng</language><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20220259247$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,873,885,64059</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/17629618$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD</creatorcontrib><title>SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF</title><description>A class of compounds as a SGLT1/SGLT2/DPP4 triple inhibitor, and an application in preparation of a drug serving as the SGLT1/SGLT2/DPP4 triple inhibitor. Compounds represented by formula (I), and isomers and pharmaceutically-acceptable salts thereof are specifically involved.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNrjZNAJdvcJCdZ3CQgwUfD08_B08gzxD1Jw9HNRcAwI8PF0dgzx9PdTCPFwDXL1d-NhYE1LzClO5YXS3Axqbq4hzh66pcUFiSWpeSXF8YkFBTmZyYklmfl5xfGG5mZGlmaGFsZEKwQAkRIrHQ</recordid><startdate>20200724</startdate><enddate>20200724</enddate><creator>DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD</creator><scope>EFI</scope></search><sort><creationdate>20200724</creationdate><title>SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_176296183</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><aucorp>DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., LTD</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF</title><date>2020-07-24</date><risdate>2020</risdate><abstract>A class of compounds as a SGLT1/SGLT2/DPP4 triple inhibitor, and an application in preparation of a drug serving as the SGLT1/SGLT2/DPP4 triple inhibitor. Compounds represented by formula (I), and isomers and pharmaceutically-acceptable salts thereof are specifically involved.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_uspatents_applications_17629618
source	USPTO Published Applications
title	SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A07%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.aucorp=DONGBAO%20PURPLE%20STAR%20(HANGZHOU)%20BIOPHARMACEUTICAL%20CO.,%20LTD&rft.date=2020-07-24&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20220259247%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true